Skip to main content

Accelerated Technologies Center for Gene to 3D Structure

Go Search
Home
About
Background
Biomedical Applications
Technologies
Facilities
Targets
Contact Us
  
Accelerated Technologies Center for Gene to 3D Structure > Pages > biomedical  

 

GPCRs as Structural Targets at the ATCG3D

 

·         Over 1,000 G protein-coupled receptors (GPCRs) are expressed in the human genome.

 

·         These transmembrane signal transduction proteins mediate a majority of cell-cell communication in humans and other vertebrates.

 

·         Specifically, GPCRs are responsible for the initiation (and in some cases regulation) of a vast range of cellular processes including neurotransmission and homeostasis.

 

·         Ligand binding to the cell surface-exposed region of the GPCR followed by conformational activation of the associated cytoplasmic G-protein constitutes the mechanism of signal transduction.

 

·         Stimulatory ligands and activators include macromolecules, hormones, neurotransmitters, odorants, and light. GPCRs with unidentified stimulatory ligands are labeled orphan GPCRs.

 

·         G-protein and receptor identities are defined by the G-protein alpha-subunit because it is the unique region that interacts with the GPCR and various effector components inside the cell.

 

·         GPCRs constitute roughly half of all modern pharmaceutical drug targets.

 

·         Despite their ubiquity, only four GPCR structures have been solved to date, bovine rhodopsin, turkey beta-1-adrenergic receptor, human beta-2-adrenergic receptor, and human adenosine A2A.

 

·         GPCRs are difficult targets for crystallographic characterization, due to their water-insoluble transmembrane domains, large size, and poor stability.

 

·         Ongoing robotic screening and LCP crystallization techniques are successfully employed in the crystallographic characterization of target GPCRs.

 

·         Agonist, antagonist, and inverse agonists are functionally studied in complex with their associated GPCRs, both structurally and biochemically.

 

·         The ATCG3D structure production program is exclusively focused on the high-resolution structure determination of human GPCRs and their complexes.

 

·         Technologies developed through this work provide improved tools for macromolecular crystallography that reduce the time and resources required for membrane protein structure determination.

 

·         Results from our studies of GPCRs and the associated complexes provide fundamental knowledge in the areas of cell biology, biochemistry, and human health.